Hester Biosciences Ltd:AVOID

Dear Mahesh ji

I want your view on Hester Biosciences..

Ripal

1. Hester Biosciences Ltd is a 10 rupee face value Pharmaceuticals company. ( Animal or Veterinary drugs)

2. Year high of Hester Biosciences Ltd is 849 year low was 302 and stock traded at 571.25, Year high/ low ratio is  above 2 so as my theory current market price is not  stable and this stock may down more from here,  If you are new reader of my blog and not familiar with my research terms then please see my research terms at this link

Research Terms of Mahesh Kaushik

3. Promoters of Hester Biosciences Ltd hold 54.07 %FII hold 0.50 % and DII hold 1.69%. Promoters not pledged any stok so this is a  good point.

4.Hester Biosciences Ltd Give  3.10 to 1.00 rupee dividend in last some years

5. Base price of Hester Biosciences Ltd is 284 So CMP is more than double of base price so It is risky to buy this stock above 284, please note base price is not used for technical trades we use base price for long term cheap buy.

6. No any bonus issue right issue and bulk deals is recorded  in last 2 year.

6. Hester Biosciences Ltd net sale per share of Fy 14-15 is 105.84.

7. Net sale per share also suggest that below 105 is a fair value for value investor like me.

8. Book value of Hester Biosciences Ltd is 101.13 CMP is higher   then book value so in book value concept this stock is not a value buy. But Net sale per share and book value both suggest that this stock is best long term buy below 100 and at CMP this is an Avoid

8. Overall this stock is a good If available below 100 and you may book your profit or avoid fresh buy at CMP.

9. 200 DMA of Hester Biosciences Ltd is 582.20 So at CMP 571.25 Hester Biosciences Ltd  give a nagative breakout below his 200 DMA.
Click here to download last 3 year closing price with graph

10. My recent updates :- Past Performance of My Recommendations.

11. Disclaimer:- This is not an advisory service to buy or sell. The contents of “this research report” are only for educational purposes. No liability is accepted for any content in “this research report”. The author is neither a registered stockbroker nor a registered advisor and does not give investment advice. His comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to buy or sell a stock, option, future, bond, commodity, index or any other financial instrument at any time.The author recommends that you consult with a qualified investment advisor, one licensed by appropriate regulatory agencies in your legal jurisdiction, before making any investment decisions. Please  read full disclaimer at the bottom of my blog.

12.Discloser:- I Mahesh Chander Kaushik author of this research report is an existing research analyst and passed NISM certification for research analysts. I am also registered under SEBI(RESEARCH ANALYSTS) REGULATIONS, 2014 ( SEBI Registration Number INH 100000908 ) hereby disclose about my financial interest in the subject company and the nature of such financial interest:- 1 Me and my associates or relatives have not hold any share of Hester Biosciences Ltd so my personal interest is not included in this stock. 2. Me and my associates or relatives have not any actual/beneficial ownership of one percent or more securities of the subject company ( Hester Biosciences Ltd). 3. Me and my associates or relatives have not any other material conflict of interest at the time of publication of the research report. 4. Me and my associates or relatives have not  received any type of compensation from the subject company(Hester Biosciences Ltd) in the past twelve months. 5. I am not served as an officer, director or employee of the subject company ( Hester Biosciences Ltd). 6. I have been not engaged in market making activity for the subject company (Hester Biosciences Ltd).